+49 152 22 82 97 73
 

Courses

Optimizing development and commercialization strategies

In a cross functional team setting participants will understand how to optimize a clinical development program for a successful pricing and commercialization strategy over its life cycle

They will learn 

  • Hard skills
    • How different parameters of clinical development affect the label, Health Technology Assessments (HTA), pricing & reimbursement and commercialization over the product lifecycle.
    • To generate strategic options and evaluate them on parameters such as duration, cost, probability of technical success, commercial value etc. and finally make a decision*
    • To deal with the consequences of their decisions
    • How to present to internal and external review bodies
  • Soft skills
    • To understand the principles of cross functional team work and their individual roles within them
    • How they can individually optimize their behaviors to the benefit of team performance

Tutors

  • Dr. Stefan Walzer (General Manager, MArS Market Access & Pricing Strategy GmbH)
  • Dr. Siegfried Schuetzinger (Training Specialist)
  • Ing. Des Markland (Director, Decanalysis Ltd.) 

Health economic tools to improve sales and revenues in Germany

Health economics could support the purchasing and reimbursement decisions by various stakeholders in Germany. MArS and the medical device association BVMed have organized a one-day conference in November 2016 for the fourth time to discuss the different health economic tools available for different situations in the German context of medical devices. Slides and information are available on request.

Tutors

  • Dr. Stefan Walzer (General Manager, MArS Market Access & Pricing Strategy GmbH)
  • PD Dr. Dominik Franz (Director Medical Controlling, DRG Research Group, University clinic of Muenster) 

Selective contracts in the context of market access for Medical Devices in Germany

Selective contracts could be the only or a timely opportunity market access solution for medical devices in Germany. MArS and the medical device association BVMed are organizing a one-day conference on July 5 2016 to discuss the different current and future perspectives of selective contracts in the German context of medical device market access in Berlin. Slides and further information are available on request. 

Tutors

  • Dr. Stefan Walzer (General Manager, MArS Market Access & Pricing Strategy GmbH)
  • Dr. Gerhard Nitz und Dr. Julian Braun (Lawyers, Dierks + Bohle Rechtsanwälte Partnerschaft mbB)
  • Dr. Jan Helfrich (DAK-Gesundheit)
  • Dr. Helmut Hildebrand (Geschäftsführer Gesundes Kinzigtal GmbH, Hausach, Vorstand Optimedis AG, Hamburg) 

Lifecycle management from a market access perspective

Large and small companies both need to request and defend their investments and plan accordingly to succeed with their compounds in the future in the respective markets. MArS in conjunction with the biotechnology association Bio-M have developed a dedicated seminar on the lifecycle approach for companies including the important market access perspective.

The seminar was a big success and further information are available on request.

Tutors

  • Dr. Stefan Walzer (General Manager, MArS Market Access & Pricing Strategy GmbH)
  • Dr. Elmar Stridde (ECHOconsult)